{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:30:44Z","timestamp":1754145044196,"version":"3.41.2"},"reference-count":46,"publisher":"Informa UK Limited","issue":"4","funder":[{"name":"State Council of Science and Technology of the State of Durango"},{"DOI":"10.13039\/501100003141","name":"National Council of Humanities, Sciences and Technologies","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Drug and Chemical Toxicology"],"published-print":{"date-parts":[[2025,7,4]]},"DOI":"10.1080\/01480545.2024.2415343","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T05:03:33Z","timestamp":1729055013000},"page":"743-757","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Population pharmacokinetics and pharmacodynamics of L-asparaginase and its impact on the development of pancreatitis and hypersensitivity reactions in children with leukemia under treatment"],"prefix":"10.1080","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5927-4992","authenticated-orcid":false,"given":"Jes\u00fas Alonso","family":"G\u00e1ndara-Mireles","sequence":"first","affiliation":[{"name":"Academia de Gen\u00f3mica, Instituto Polit\u00e9cnico Nacional, CIIDIR-Unidad Durango","place":["Durango, M\u00e9xico"]},{"name":"Red Latinoamericana de Implementaci\u00f3n y Validaci\u00f3n de Gu\u00edas Cl\u00ednicas Farmacogen\u00f3micas (RELIVAF-CYTED)","place":["Santiago, Chile"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5124-4556","authenticated-orcid":false,"given":"Ismael","family":"Lares-Asseff","sequence":"additional","affiliation":[{"name":"Academia de Gen\u00f3mica, Instituto Polit\u00e9cnico Nacional, CIIDIR-Unidad Durango","place":["Durango, M\u00e9xico"]},{"name":"Red Latinoamericana de Implementaci\u00f3n y Validaci\u00f3n de Gu\u00edas Cl\u00ednicas Farmacogen\u00f3micas (RELIVAF-CYTED)","place":["Santiago, Chile"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elio Aar\u00f3n Reyes","family":"Espinoza","sequence":"additional","affiliation":[{"name":"Servicio de Hemato-Oncolog\u00eda Pedi\u00e1trica, Centro Estatal de Cancerolog\u00eda, CECAN Durango","place":["Durango, M\u00e9xico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4158-1078","authenticated-orcid":false,"given":"Ver\u00f3nica","family":"Loera-Casta\u00f1eda","sequence":"additional","affiliation":[{"name":"Academia de Gen\u00f3mica, Instituto Polit\u00e9cnico Nacional, CIIDIR-Unidad Durango","place":["Durango, M\u00e9xico"]},{"name":"Red Latinoamericana de Implementaci\u00f3n y Validaci\u00f3n de Gu\u00edas Cl\u00ednicas Farmacogen\u00f3micas (RELIVAF-CYTED)","place":["Santiago, Chile"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flor de Mar\u00eda","family":"Reyes Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"Servicio de Pediatr\u00eda, Instituto Materno Infantil del Estado de M\u00e9xico","place":["Toluca, M\u00e9xico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6359-9394","authenticated-orcid":false,"given":"Antonio","family":"Sandoval-Cabrera","sequence":"additional","affiliation":[{"name":"Servicio de Pediatr\u00eda, Instituto Materno Infantil del Estado de M\u00e9xico","place":["Toluca, M\u00e9xico"]},{"name":"Facultad de Medicina, Universidad Aut\u00f3noma del Estado de M\u00e9xico","place":["Toluca, M\u00e9xico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes Patricia C\u00f3rdova","family":"Hurtado","sequence":"additional","affiliation":[{"name":"Servicio de Hemato-Oncolog\u00eda Pedi\u00e1trica, Centro Estatal de Cancerolog\u00eda, CECAN Durango","place":["Durango, M\u00e9xico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia Mora","family":"Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Servicio Epidemiolog\u00eda, Centro Estatal de Cancerolog\u00eda, CECAN Durango","place":["Durango, M\u00e9xico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Villanueva Fierro","sequence":"additional","affiliation":[{"name":"Academia de Gen\u00f3mica, Instituto Polit\u00e9cnico Nacional, CIIDIR-Unidad Durango","place":["Durango, M\u00e9xico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Payan Gandara","sequence":"additional","affiliation":[{"name":"Servicio Epidemiolog\u00eda, Centro Estatal de Cancerolog\u00eda, CECAN Durango","place":["Durango, M\u00e9xico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8981-055X","authenticated-orcid":false,"given":"Leslie","family":"Patr\u00f3n-Romero","sequence":"additional","affiliation":[{"name":"Facultad de Medicina y Psicolog\u00eda, Universidad Aut\u00f3noma de Baja California","place":["Tijuana Baja California, M\u00e9xico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1874-3975","authenticated-orcid":false,"given":"Horacio","family":"Almanza-Reyes","sequence":"additional","affiliation":[{"name":"Red Latinoamericana de Implementaci\u00f3n y Validaci\u00f3n de Gu\u00edas Cl\u00ednicas Farmacogen\u00f3micas (RELIVAF-CYTED)","place":["Santiago, Chile"]},{"name":"Facultad de Medicina y Psicolog\u00eda, Universidad Aut\u00f3noma de Baja California","place":["Tijuana Baja California, M\u00e9xico"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002800100286"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000000837"},{"key":"e_1_3_5_4_1","unstructured":"Asparaginase Activity Assay. (2023). Enzymatic asparaginase activity assay. Sigmaaldrich.com. Retrieved March 17 2023 from https:\/\/www.sigmaaldrich.com\/MX\/es\/technical-documents\/technical-article\/research-and-disease-areas\/cell-signaling\/asparaginase-activity-assay-kit-mak007"},{"key":"e_1_3_5_5_1","unstructured":"Asparagine Assay Kit (Fluorometric). (2023). Retrieved March 17 2023 from https:\/\/www.abcam.com\/ps\/products\/273\/ab273333\/documents\/Asparagine-assay-protocol-book-v2-ab273333%20(website).pdf"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.1003056"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.2147\/DIJN.1.S623"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21584"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1976.tb03563.x"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.3109\/08880018.2011.627978"},{"issue":"3","key":"e_1_3_5_11_1","first-page":"335","article-title":"Adverse reactions of L-asparaginase","volume":"4","author":"Cairo M. S.","year":"1982","unstructured":"Cairo, M. S. (1982). Adverse reactions of L-asparaginase. The American Journal of Pediatric Hematology\/Oncology, 4(3), 335\u2013339.","journal-title":"The American Journal of Pediatric Hematology\/Oncology"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-020-09695-z"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000002368"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-021-01796-w"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.117.199638"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.21037\/tp-20-178"},{"issue":"9","key":"e_1_3_5_17_1","first-page":"600","article-title":"Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia","volume":"7","author":"Earl M.","year":"2009","unstructured":"Earl, M. (2009). Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia. Clinical Advances in Hematology & Oncology: H&O, 7(9), 600\u2013606.","journal-title":"Clinical Advances in Hematology & Oncology: H&O"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-014-2464-2"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111616"},{"key":"e_1_3_5_20_1","volume-title":"Pediatric blood & cancer","author":"Gandara Mireles J. A.","year":"2023","unstructured":"Gandara Mireles, J. A., Lares-Asseff, I., Reyes Espinoza, E., Cordova Hurtado, L., Diaz Gonzalez, C., et\u00a0al. (2023). Population pharmacokinetics and pharmacodynamics of l-asparaginase and its impact on the development of pancreatitis and hypersensitivity reactions in children with all under treatment. In Pediatric blood & cancer (Vol. 70). Wiley. https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/siop23\/SIOP_2023_Poster_Viewing_Abstracts_Oct_9.pdf"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/10781552221117810"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-021-00463-1"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.2165\/11318100-000000000-00000"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01120-1"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.803224"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.18433\/J3GP53"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2019.01.013"},{"key":"e_1_3_5_28_1","unstructured":"National Cancer Institute. (2009). Common terminology criteria for adverse events v4.03. Handydex. Retrieved March 17 2023 from https:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03\/Archive\/CTCAE_4.0_2009-05-29_QuickReference_8.5x11.pdf"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200404000-00002"},{"key":"e_1_3_5_30_1","unstructured":"PASW Statistics 18. (2009). Release Version 18.0.0. SPSS Inc. www.spss.com"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-149443"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25489"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0900386"},{"key":"e_1_3_5_34_1","volume-title":"*RStudio: Integrated development environment for R*","author":"RStudio Team","year":"2023","unstructured":"RStudio Team (2023). *RStudio: Integrated development environment for R*. RStudio, PBC. https:\/\/www.rstudio.com\/"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2020.07.008"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.149195"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10194419"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.958666"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.04.006"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.9.2888-2891.2003"},{"key":"e_1_3_5_41_1","unstructured":"TIBCO Statistica\u00ae. 13.3.0 https:\/\/docs.tibco.com\/products\/ tibco-statistica-13-3-0"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-534347"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.2070"},{"key":"e_1_3_5_44_1","unstructured":"Weiss C. H. (2008). Commercial meets Open Source: Tuning STATISTICA with R. R-Project. March."},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30424-2"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1177\/1533033820980113"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-021-00670-8"}],"container-title":["Drug and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/01480545.2024.2415343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T09:56:44Z","timestamp":1752659804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/01480545.2024.2415343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7,4]]}},"alternative-id":["10.1080\/01480545.2024.2415343"],"URL":"https:\/\/doi.org\/10.1080\/01480545.2024.2415343","relation":{},"ISSN":["0148-0545","1525-6014"],"issn-type":[{"type":"print","value":"0148-0545"},{"type":"electronic","value":"1525-6014"}],"subject":[],"published":{"date-parts":[[2024,10,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idct20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idct20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-07-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}